-
1
-
-
0028179558
-
Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors
-
Altman DG, Lausen B, Sauerbrei W and Schumacher M (1944) Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835
-
(1944)
J Natl Cancer Inst
, vol.86
, pp. 829-835
-
-
Altman, D.G.1
Lausen, B.2
Sauerbrei, W.3
Schumacher, M.4
-
2
-
-
0029121680
-
Novel methods for the determination of the angiogenic activity of human tumors
-
Barbareschi M, Gasparini G, Morelli L, Forti S and Della-Palma P (1995) Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat 36: 181-192
-
(1995)
Breast Cancer Res Treat
, vol.36
, pp. 181-192
-
-
Barbareschi, M.1
Gasparini, G.2
Morelli, L.3
Forti, S.4
Della-Palma, P.5
-
4
-
-
0028309791
-
Urokinase plasminogen activator (uPA) and its type I inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer
-
Brünner N, Pyke C, Hansen CH, Romer J, Grøndahl-Hansen J and Danø K (1994) Urokinase plasminogen activator (uPA) and its type I inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treat Res 71: 299-309
-
(1994)
Cancer Treat Res
, vol.71
, pp. 299-309
-
-
Brünner, N.1
Pyke, C.2
Hansen, C.H.3
Romer, J.4
Grøndahl-Hansen, J.5
Danø, K.6
-
5
-
-
0000336139
-
Regression models and life-tables
-
Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34: 187-200
-
(1972)
J R Stat Soc (B)
, vol.34
, pp. 187-200
-
-
Cox, D.R.1
-
6
-
-
0023735157
-
Urokinase-plasminogen activator, a marker for aggressive breast carcinomas
-
Duffy M, O'Grady P, Devaney D, O'Siorain L, Fennelly JJ and Lijnen HJ (1988). Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Cancer 62: 531-533
-
(1988)
Cancer
, vol.62
, pp. 531-533
-
-
Duffy, M.1
O'Grady, P.2
Devaney, D.3
O'Siorain, L.4
Fennelly, J.J.5
Lijnen, H.J.6
-
7
-
-
0025013834
-
Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer
-
Duffy MJ, Reilley D, O'Sullivan C, O'Higgins N, Fennelly JN and Andreasen P (1990) Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res 50: 6827-6829
-
(1990)
Cancer Res
, vol.50
, pp. 6827-6829
-
-
Duffy, M.J.1
Reilley, D.2
O'Sullivan, C.3
O'Higgins, N.4
Fennelly, J.N.5
Andreasen, P.6
-
8
-
-
0029065722
-
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
-
Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ and Duffy MJ (1995) Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 61: 597-600
-
(1995)
Int J Cancer
, vol.61
, pp. 597-600
-
-
Duggan, C.1
Maguire, T.2
McDermott, E.3
O'Higgins, N.4
Fennelly, J.J.5
Duffy, M.J.6
-
9
-
-
0025336879
-
The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
-
Estreicher A, Muhlhauser J, Carpentier JL, Orci L and Vassalli JD (1990) The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111: 783-792
-
(1990)
J Cell Biol
, vol.111
, pp. 783-792
-
-
Estreicher, A.1
Muhlhauser, J.2
Carpentier, J.L.3
Orci, L.4
Vassalli, J.D.5
-
11
-
-
0028048915
-
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer
-
Foekens JA, Schmitt M, van Putten WLJ, Peters HA, Jänicke F and Klijn JMG (1994) Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol 12: 1648-1658
-
(1994)
J Clin Oncol
, vol.12
, pp. 1648-1658
-
-
Foekens, J.A.1
Schmitt, M.2
Van Putten, W.L.J.3
Peters, H.A.4
Jänicke, F.5
Klijn, J.M.G.6
-
12
-
-
0026440080
-
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients
-
Foekens JA, Schmitt M, van Putten WLJ, Peters HA, Bontenbal M, Jänicke F and Klijn JGM (1992) Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 52: 6101-6105
-
(1992)
Cancer Res
, vol.52
, pp. 6101-6105
-
-
Foekens, J.A.1
Schmitt, M.2
Van Putten, W.L.J.3
Peters, H.A.4
Bontenbal, M.5
Jänicke, F.6
Klijn, J.G.M.7
-
13
-
-
0027935805
-
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
-
Ganesh S, Sier CF, Griffioen G, Vloedgraven HJ, de Boer A, Welvaart K, van de Velde CJ, van Krieken JH, Verheijen JH, Lamers CB and Verspaget HW (1994) Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54: 4065-4071
-
(1994)
Cancer Res
, vol.54
, pp. 4065-4071
-
-
Ganesh, S.1
Sier, C.F.2
Griffioen, G.3
Vloedgraven, H.J.4
De Boer, A.5
Welvaart, K.6
Van De Velde, C.J.7
Van Krieken, J.H.8
Verheijen, J.H.9
Lamers, C.B.10
Verspaget, H.W.11
-
14
-
-
21144472187
-
Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis
-
Gray RJ (1992). Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis. J Am Stat Assoc 87: 942-951
-
(1992)
J Am Stat Assoc
, vol.87
, pp. 942-951
-
-
Gray, R.J.1
-
15
-
-
0027223048
-
High levels of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
-
Grøndahl-Hansen J, Christensen IJ, Rosenquist C, Rosenquist C, Brünner N, Mouridsen HT, Danø K and Blichert-Toft M (1993) High levels of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 53: 2513-2521
-
(1993)
Cancer Res
, vol.53
, pp. 2513-2521
-
-
Grøndahl-Hansen, J.1
Christensen, I.J.2
Rosenquist, C.3
Rosenquist, C.4
Brünner, N.5
Mouridsen, H.T.6
Danø, K.7
Blichert-Toft, M.8
-
16
-
-
0024576759
-
Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder
-
Hasui Y, Suzumiya J, Marutsuka K, Sumiyoshi A, Hashida S and Ishikawa E (1989) Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder. Cancer Res 49: 1067-1070
-
(1989)
Cancer Res
, vol.49
, pp. 1067-1070
-
-
Hasui, Y.1
Suzumiya, J.2
Marutsuka, K.3
Sumiyoshi, A.4
Hashida, S.5
Ishikawa, E.6
-
17
-
-
0028885643
-
Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer
-
Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW and Schildberg FW (1995) Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer. Nature Med 1: 1035-1039
-
(1995)
Nature Med
, vol.1
, pp. 1035-1039
-
-
Heiss, M.M.1
Allgayer, H.2
Gruetzner, K.U.3
Funke, I.4
Babic, R.5
Jauch, K.W.6
Schildberg, F.W.7
-
18
-
-
0029097254
-
Tumor associated proteolysis and prognosis: New functional risk factors in gastric cancer defined by the urokinase type plasminogen activator system
-
Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch KW, Loehrs U and Schildberg FW (1995) Tumor associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase type plasminogen activator system. J Clin Oncol 13: 2084-2093
-
(1995)
J Clin Oncol
, vol.13
, pp. 2084-2093
-
-
Heiss, M.M.1
Babic, R.2
Allgayer, H.3
Gruetzner, K.U.4
Jauch, K.W.5
Loehrs, U.6
Schildberg, F.W.7
-
19
-
-
0030061899
-
Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer
-
Hofmann R, Lehmer A, Hartung R, Robrecht C, Buresch M and Grothe F (1996) Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer. J Urol 155: 858-862
-
(1996)
J Urol
, vol.155
, pp. 858-862
-
-
Hofmann, R.1
Lehmer, A.2
Hartung, R.3
Robrecht, C.4
Buresch, M.5
Grothe, F.6
-
20
-
-
0028951043
-
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
-
Holmgren L, O'Reilly MS and Folkman J (1995) Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 2: 149-153
-
(1995)
Nature Med
, vol.2
, pp. 149-153
-
-
Holmgren, L.1
O'Reilly, M.S.2
Folkman, J.3
-
21
-
-
0028358771
-
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor type I
-
Jänicke F, Pache L, Schmitt M, Ulm K, Thomssen Ch, Prechtl A and Graeff H (1994) Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor type I. Cancer Res 54: 2527-2530
-
(1994)
Cancer Res
, vol.54
, pp. 2527-2530
-
-
Jänicke, F.1
Pache, L.2
Schmitt, M.3
Ulm, K.4
Thomssen, Ch.5
Prechtl, A.6
Graeff, H.7
-
22
-
-
0025995880
-
Clinical relevance of the urokinase-type and the tissue-type plasminogen activators and of their inhibitor PAI-1 in breast cancer
-
Jänicke F, Schmitt M and Graeff H (1991) Clinical relevance of the urokinase-type and the tissue-type plasminogen activators and of their inhibitor PAI-1 in breast cancer. Semin Thromb Hemostas 17: 303-312
-
(1991)
Semin Thromb Hemostas
, vol.17
, pp. 303-312
-
-
Jänicke, F.1
Schmitt, M.2
Graeff, H.3
-
23
-
-
0025127815
-
Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
-
Jänicke F, Schmitt M, Hafter R, Hollrieder A, Babic R, Ulm K, Gössner W and Graeff H (1990) Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 4: 69-78
-
(1990)
Fibrinolysis
, vol.4
, pp. 69-78
-
-
Jänicke, F.1
Schmitt, M.2
Hafter, R.3
Hollrieder, A.4
Babic, R.5
Ulm, K.6
Gössner, W.7
Graeff, H.8
-
24
-
-
0027082979
-
Urokinase (uPA) and its inhibitor PAI-1 are strong, independent prognostic factors in node-negative breast cancer
-
Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H and Graeff H (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong, independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195-208
-
(1993)
Breast Cancer Res Treat
, vol.24
, pp. 195-208
-
-
Jänicke, F.1
Schmitt, M.2
Pache, L.3
Ulm, K.4
Harbeck, N.5
Höfler, H.6
Graeff, H.7
-
25
-
-
0029873910
-
The urokinase receptor is a major vitronectin-binding protein on endothelial cells
-
Kanse S, Kost C, Wilhelm O, Andreasen PA and Preissner KT (1996) The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 224: 344-353
-
(1996)
Exp Cell Res
, vol.224
, pp. 344-353
-
-
Kanse, S.1
Kost, C.2
Wilhelm, O.3
Andreasen, P.A.4
Preissner, K.T.5
-
26
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
27
-
-
0028639208
-
Impact of urokinase type plasminogen activator and its inhibitor type I on prognosis in cervical cancer of the uterus
-
Kobayashi H, Fujishiro S and Terao T (1994) Impact of urokinase type plasminogen activator and its inhibitor type I on prognosis in cervical cancer of the uterus. Cancer Res 54: 6539-6548
-
(1994)
Cancer Res
, vol.54
, pp. 6539-6548
-
-
Kobayashi, H.1
Fujishiro, S.2
Terao, T.3
-
28
-
-
0028656476
-
Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy
-
Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Jänicke F and Graeff H (1994) Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. Gynecol Oncol 55: 401-409
-
(1994)
Gynecol Oncol
, vol.55
, pp. 401-409
-
-
Kuhn, W.1
Pache, L.2
Schmalfeldt, B.3
Dettmar, P.4
Schmitt, M.5
Jänicke, F.6
Graeff, H.7
-
29
-
-
0026720849
-
The changing importance of prognostic factors in breast cancer during long-term follow-up
-
Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Marin S and Syrjanen K (1992) The changing importance of prognostic factors in breast cancer during long-term follow-up. Int J Cancer 51: 698-702
-
(1992)
Int J Cancer
, vol.51
, pp. 698-702
-
-
Lipponen, P.1
Aaltomaa, S.2
Eskelinen, M.3
Kosma, V.M.4
Marin, S.5
Syrjanen, K.6
-
30
-
-
0028900705
-
Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells
-
Liu G, Shuman MA and Cohen RL (1995) Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 60: 501-506
-
(1995)
Int J Cancer
, vol.60
, pp. 501-506
-
-
Liu, G.1
Shuman, M.A.2
Cohen, R.L.3
-
31
-
-
0028321634
-
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer
-
Nekarda H, Schmitt M, Ulm K, Wenninger A, Vogelsang H, Becker K, Roder JD, Fink U and Siewert JR (1994) Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 54: 2900-2907
-
(1994)
Cancer Res
, vol.54
, pp. 2900-2907
-
-
Nekarda, H.1
Schmitt, M.2
Ulm, K.3
Wenninger, A.4
Vogelsang, H.5
Becker, K.6
Roder, J.D.7
Fink, U.8
Siewert, J.R.9
-
32
-
-
0028070859
-
Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue
-
Pedersen H, Brünner N, Francis D, Osterlind K, Rønne E, Hansen HH, Danø K and Grondahl-Hansen J (1994) Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54: 4671-4675
-
(1994)
Cancer Res
, vol.54
, pp. 4671-4675
-
-
Pedersen, H.1
Brünner, N.2
Francis, D.3
Osterlind, K.4
Rønne, E.5
Hansen, H.H.6
Danø, K.7
Grondahl-Hansen, J.8
-
34
-
-
0028081298
-
Inactive urokinase and increased levels of its inhibitor type I in colorectal cancer liver metastasis
-
Sier CM, Vloedgraven HJM, Ganesh S, Griffioen G, Quax PH, Verheijen JH, Dooijewaard G, Welvaart K, van de Velde CJ, Lamers CB and Verspaget HW (1994) Inactive urokinase and increased levels of its inhibitor type I in colorectal cancer liver metastasis. Gastroenterology 107: 1449-1456
-
(1994)
Gastroenterology
, vol.107
, pp. 1449-1456
-
-
Sier, C.M.1
Vloedgraven, H.J.M.2
Ganesh, S.3
Griffioen, G.4
Quax, P.H.5
Verheijen, J.H.6
Dooijewaard, G.7
Welvaart, K.8
Van De Velde, C.J.9
Lamers, C.B.10
Verspaget, H.W.11
-
37
-
-
0029764639
-
Regulation of integrin function by the urokinase receptor
-
Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV and Chapman HA (1996) Regulation of integrin function by the urokinase receptor. Science 273: 1551-15
-
(1996)
Science
, vol.273
, pp. 1551-1615
-
-
Wei, Y.1
Lukashev, M.2
Simon, D.I.3
Bodary, S.C.4
Rosenberg, S.5
Doyle, M.V.6
Chapman, H.A.7
-
38
-
-
0029834684
-
Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis
-
Xing RH and Rabbani SA (1996) Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis. Int J Cancer 67: 423-429
-
(1996)
Int J Cancer
, vol.67
, pp. 423-429
-
-
Xing, R.H.1
Rabbani, S.A.2
-
39
-
-
0027428678
-
Time dependency of the influence of prognostic factors on relapse in breast cancer
-
Yoshimoto M, Sakamoto G and Ohashi Y (1993) Time dependency of the influence of prognostic factors on relapse in breast cancer. Cancer 10: 2993-3001
-
(1993)
Cancer
, vol.10
, pp. 2993-3001
-
-
Yoshimoto, M.1
Sakamoto, G.2
Ohashi, Y.3
|